BM-002
Scenario
This case tests detection of a pricing deviation above APLMA benchmark levels. The Gamma Consortium syndicated facility's Tranche B margin (245 bps) is materially above the APLMA benchmark for a comparable borrower profile (BBB-equivalent, APAC market, 5-year term). The expected system behavior is to: (1) identify the deviation, (2) state the deal margin vs. the benchmark range, (3) quantify the gap in basis points above the benchmark midpoint, and (4) cite the APLMA benchmark reference. Tranche A (185 bps) and the RCF (160 bps) are within market standard and should not be flagged. The system must not apply a single-deal assessment where per-tranche analysis is required for a multi-tranche facility.
Input
Document: gamma-consortium-syndicated.pdf
Task: Perform benchmark terms validation against applicable APLMA standards. This is a multi-tranche syndicated facility — assess each tranche separately. For any deviation found, provide: deal term, benchmark term, quantified gap (in bps or other unit), and APLMA benchmark citation.
Expected Output
| Tranche | Term | Deal Value | APLMA Benchmark | Assessment | Gap |
|---|---|---|---|---|---|
| Tranche A | Margin | 185 bps per annum | 150–220 bps (BBB-equivalent, APAC, 7-year term loan) | Market-standard — within benchmark range | — |
| Tranche B | Margin | 245 bps per annum | 150–220 bps (BBB-equivalent, APAC, 5-year term loan) | Deviation — ABOVE benchmark | +25 bps above upper end of benchmark range |
| Tranche C (RCF) | Margin | 160 bps per annum | 130–185 bps (BBB-equivalent, APAC, RCF) | Market-standard — within benchmark range | — |
| All Tranches | Reference Rate | Term SOFR (1M / 3M / 6M by tranche) | SOFR standard for USD APAC facilities | Market-standard | — |
| All Tranches | Governing Law | English law | APLMA standard | Market-standard | — |
Deviation detail — Tranche B:
- Deal margin: 245 bps per annum
- APLMA benchmark range for comparable BBB-equivalent borrower, APAC market, 5-year term loan: 150–220 bps (per APLMA Primary Market Guide, Investment Grade Pricing Matrix 2025)
- Gap: +25 bps above the upper boundary of the benchmark range
- Interpretation: Tranche B is priced above market standard. This may reflect a risk premium for the borrower's sector, covenant package, or specific deal characteristics. Analyst review recommended.
Ground Truth Citation
Tranche B Margin (Deviation Field)
"The rate of interest applicable to Tranche B Loans shall be the aggregate of (i) 2.45% per annum (the 'Tranche B Margin') and (ii) 3-month Term SOFR as published by CME Group Benchmark Administration Limited for the relevant Interest Period."
Source: gamma-consortium-syndicated.pdf, Page 22, Clause 9.2(b) (Interest — Tranche B)
Tranche A Margin (Market-Standard)
"The rate of interest applicable to Tranche A Loans shall be the aggregate of (i) 1.85% per annum (the 'Tranche A Margin') and (ii) 6-month Term SOFR as published by CME Group Benchmark Administration Limited for the relevant Interest Period."
Source: gamma-consortium-syndicated.pdf, Page 22, Clause 9.2(a) (Interest — Tranche A)
Tranche C Margin (Market-Standard)
"The rate of interest applicable to Revolving Loans shall be the aggregate of (i) 1.60% per annum (the 'RCF Margin') and (ii) 1-month Term SOFR for the applicable Interest Period."
Source: gamma-consortium-syndicated.pdf, Page 23, Clause 9.2(c) (Interest — Tranche C)
Benchmark authority note: APLMA Primary Market Guide (2025 edition), Investment Grade Pricing Matrix, applicable to APAC BBB-equivalent syndicated loans.
Scoring Criteria
| Condition | Score |
|---|---|
| Tranche B deviation correctly identified with 245 bps deal value; APLMA benchmark range cited; gap of +25 bps above upper bound stated; Tranche A and RCF correctly assessed as market-standard | 1.0 |
| Tranche B deviation identified; gap quantified but benchmark range cited incorrectly or imprecisely (e.g., midpoint used instead of upper bound) | 0.75 |
| Tranche B flagged as "potential deviation" but gap not quantified | 0.60 |
| Tranche A incorrectly flagged as deviation (false positive) | 0.50 maximum |
| All three tranches assessed together as a blended figure rather than per-tranche | 0.25 |
| Tranche B deviation missed entirely (true positive not found) | 0.0 for BMT capability |
| Benchmark range value fabricated without citation | 0.0 (case-level) |
Known Failure Modes
- Blending all three tranche margins into an average and comparing the average to benchmark (this masks Tranche B's above-market pricing).
- Flagging 185 bps (Tranche A) as a deviation because it is confused with the Tranche B rate.
- Using an LMA (European) benchmark instead of APLMA for this APAC deal, resulting in different benchmark ranges and potentially incorrect deviation flags.
- Failing to quantify the deviation in basis points — stating only "above market" without a number.
- Citing APLMA 2020 pricing matrix data rather than 2025 data, which has different market rate ranges.
Regression Note
N/A — initial case